Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | London | GBP | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GSK | NYSE | USD | Real-time | |
GLAXF | OTC Markets | USD | Delayed | |
GSKN | Mexico | MXN | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 7376 | 7829 | 6929 | 7190 |
Gross Profit | 5190 | 5443 | 4784 | 4500 |
Operating Income | 1415 | 2361 | 1709 | 1708 |
Net Income | 2001 | 10315 | 838 | 1802 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 60146 | 60313 | 89045 | 89689 |
Total Liabilities | 50050 | 51597 | 66405 | 67057 |
Total Equity | 10096 | 8716 | 22640 | 22632 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1905 | 1321 | 2542 | |
Cash From Investing Activities | -540 | -4094 | -3593 | |
Cash From Financing Activities | -1338 | -1326 | 7973 | |
Net Change in Cash | 73 | -4076 | 6934 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review